1019381-31-7 | {1-[2-(dimethylamino)ethyl]piperidin-4-yl}methanamine

Packsize	Purity	Availability	Price	Discounted Price
50mg	97%	1 week	$254.00	$178.00
100mg	97%	1 week	$354.00	$248.00
250mg	97%	1 week	$485.00	$340.00
500mg	97%	1 week	$772.00	$541.00
1g	97%	1 week	$974.00	$682.00
2.5g	97%	1 week	$1,858.00	$1,301.00
5g	97%	1 week	$2,726.00	$1,908.00
10g	97%	1 week	$4,017.00	$2,812.00

Description

• Catalog Number: AV42509
• Chemical Name: {1-[2-(dimethylamino)ethyl]piperidin-4-yl}methanamine
• CAS Number: 1019381-31-7
• Molecular Formula: C10H23N3
• Molecular Weight: 185.3097
• MDL Number: MFCD11131485
• SMILES: NCC1CCN(CC1)CCN(C)C

Upstream Synthesis Route

The compound {1-[2-(Dimethylamino)ethyl]piperidin-4-yl}methanamine, also known by its chemical formula, is a versatile molecule frequently employed in chemical synthesis for its unique properties and reactivity. Its primary application lies in organic chemistry, particularly in the synthesis of various pharmaceuticals and biologically active molecules.In chemical synthesis, {1-[2-(Dimethylamino)ethyl]piperidin-4-yl}methanamine acts as a valuable building block due to its well-defined structure and functional groups. Its amine group serves as a site for selective functionalization, allowing for the introduction of new substituents or modification of the molecule to create derivatives with specific properties.Furthermore, the piperidine ring in the structure confers additional stability and conformational rigidity, making it a popular choice for designing molecular scaffolds in drug discovery efforts. The presence of the dimethylaminoethyl side chain further enhances the compound's utility by providing a flexible linker that can be easily manipulated to control the compound's pharmacokinetic properties and target interactions.Overall, {1-[2-(Dimethylamino)ethyl]piperidin-4-yl}methanamine plays a crucial role in the development of novel compounds with therapeutic potential, making it a cornerstone in the toolkit of synthetic chemists working in the pharmaceutical and biotechnology industries.